Neuromuscular-targeting compound 1

CAT:

804-HY-U00310

Size:

Inquire

Price:

Ask

For price, please contact [email protected]

CAS Number: 1178978-20-5
UNSPSC Description: Neuromuscular-targeting compound 1, extracted from patent WO2009099594 A1, Paragraph 0100, is useful in treatment of neuromuscular diseases.
Target Antigen: Others
Type: Reference compound
Related Pathways: Others
Applications: Neuroscience-Neuromodulation
Field of Research: Neurological Disease
Assay Protocol: https://www.medchemexpress.com/2H-Imidazo[4,5-b]pyridin-2-one,_6-chloro-1-_1-ethylpropyl_-1,3-dihydro-7-_2H-tetrazol-5-yl_-.html
Solubility: 10 mM in DMSO
Smiles: O=C1NC2=NC=C(Cl)C(C3=NNN=N3)=C2N1C(CC)CC
Molecular Weight: 307.74
References & Citations: [1]YANG, Zhe, et al. CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS. WO2009099594A1.
Shipping Conditions: Room temperature
Clinical Information: No Development Reported

Cat	Name
HY-U00310	Neuromuscular-targeting compound 1
HY-U00385	Neuromuscular Disorder-Targeting Compound 1
HY-U00361	Itch-Targeting Compound 1
HY-U00300	Cancer-Targeting Compound 1
HY-U00393	Arrhythmic-Targeting Compound 1
HY-101750	Arrhythmias-Targeting Compound 1
HY-U00362	Neurodegenerative Disorder-Targeting Compound 1
HY-U00357	Urinary Incontinence-Targeting Compound 1
HY-U00362A	(Rac)-Neurodegenerative Disorder-Targeting Compound 1
HY-P10055	PSMA targeting peptide

Cat	Name
MBS5767935-01	Neuromuscular-targeting compound 1
T13491-10mg	Neuromuscular-targeting compound 1
T13491-1g	Neuromuscular-targeting compound 1
MBS5767935-02	Neuromuscular-targeting compound 1
T13491-5mg	Neuromuscular-targeting compound 1
T13491-1mg	Neuromuscular-targeting compound 1
T13491-50mg	Neuromuscular-targeting compound 1
T10059-1mg	Neuromuscular Disorder-Targeting Compound 1
T10059-10mg	Neuromuscular Disorder-Targeting Compound 1
T10059-5mg	Neuromuscular Disorder-Targeting Compound 1